vyzultahcp.com - Go for IOP Control From the Start

Description: VYZULTA® is a dual-action prostaglandin analog that can provide well-tolerated and sustained IOP reduction for patients with open-angle glaucoma or ocular hypertension

safety (4378) glaucoma (484) moa (89) efficacy (32) nitric oxide (27) vyzulta hcp (1) open-angle glaucoma (1) dual moa (1)

Example domain paragraphs

Significantly greater intraocular pressure (IOP) reduction vs timolol 0.5% or Xalatan (latanoprost) 0.005% in clinical trials 1-4

Cancel Confirm

VYZULTA ® (latanoprostene bunod ophthalmic solution), 0.024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Links to vyzultahcp.com (3)